AWM
ANGO icon

AE Wealth Management’s AngioDynamics ANGO Stock Holding History

AE Wealth Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,335
Closed -$86.7K – 1237
2024
Q2 		$86.7K Buy
+14,335
New +$88.5K ﹤0.01% 1202

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AE Wealth Management's ANGO Position: Q3 2024 in Review

AE Wealth Management sold out of AngioDynamics (ANGO) in Q3 2024, closing a stake of 14,335 shares — an estimated $86.7K sold.

AE Wealth Management first reported a position in ANGO in Q2 2024 and held it in 1 quarter. The position peaked at $86.7K in Q2 2024. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2024.

  • AE Wealth Management reported no remaining AngioDynamics position as of Q3 2024 after selling out during the quarter.
  • AE Wealth Management sold 14,335 AngioDynamics shares in Q3 2024, an estimated $86.7K.
  • AE Wealth Management first reported a position in AngioDynamics in Q2 2024 and held it in 1 quarter.
  • AE Wealth Management's AngioDynamics position peaked at $86.7K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2024.

Based on AE Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.